The Breakfast Study
1 other identifier
interventional
119
1 country
1
Brief Summary
The investigators will conduct an acceptability, feasibility, preliminary effectiveness trial of a 4-month, online, very low-carbohydrate breakfast-focused program in 120 adults with type 2 diabetes. The investigators will measure acceptability and feasibility, plus critical efficacy outcomes, such as changes in HbA1c, anti-hyperglycemic medications, glycemic variability, body weight, blood pressure, and lipids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 type-2-diabetes
Started Aug 2023
Longer than P75 for phase_1 type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2023
CompletedStudy Start
First participant enrolled
August 2, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2025
CompletedNovember 21, 2025
November 1, 2025
2.2 years
July 17, 2023
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intervention satisfaction
A 1-item measure about intervention satisfaction. We ask participants, "How would you rate your overall satisfaction with the program?" The item is rated from 1 = very dissatisfied to 6 = very satisfied, with higher scores reflecting greater satisfaction.
At 4 months
Secondary Outcomes (5)
Weekly dietary adherence
Weekly over 4 months
Change in diabetes treatment satisfaction
0 to 4 months
Change in health-related quality of life
0 to 4 months
Change in HbA1c
0 to 4 months
Change in anti-hyperglycemic medications
0 to 4 months
Study Arms (1)
Very low-carbohydrate breakfast
EXPERIMENTALMaterials will encourage eating a very low-carbohydrate breakfast (or first meal of the day), with no more than about 5-10 non-fiber (net) grams of carbohydrates each.
Interventions
We will provide participants recipes and information to support this dietary change.
Eligibility Criteria
You may qualify if:
- HbA1c 7% or higher
- years old
- The ability to understand verbal and written English
- Willingness to follow the prescribed diet
- Able to consent and follow directions
- Willingness to regularly check blood glucose levels as required
You may not qualify if:
- Inability to provide informed consent
- Pregnant, breastfeeding, or planning for either in the next 6 months or \<6 months postpartum
- Low C-peptide and possible subsequent GAD 65 level that suggests type 1 diabetes, clinical factors that suggest type 1 diabetes (lean, lack of family history, and diabetic ketoacidosis in the past) or a previous diagnosis of type 1 diabetes or latent autoimmune diabetes
- Cancer, heart failure, or kidney failure
- Vegan
- Untreated mental health condition
- Currently following a very low-carbohydrate diet or breakfasts
- Thyroid levels out of range
- Alcoholism
- Previous bariatric surgery
- Difficulty chewing or swallowing
- Dependence on others for food preparation
- Currently enrolled in another investigative study that might conflict with this research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Hansen A, Raymond K, Simon A, Kim S, Bayandorian H, Marriott D, Saslow LR. Very Low-Carbohydrate Breakfast Intervention for Adults with Type 2 Diabetes and Persistent Hyperglycemia: Protocol for a Digital, Nonrandomized Pre-Post Study. JMIR Res Protoc. 2026 Jan 28;15:e81041. doi: 10.2196/81041.
PMID: 41605502DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Blood tests and continuous glucose monitoring are masked.
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 17, 2023
First Posted
August 14, 2023
Study Start
August 2, 2023
Primary Completion
October 9, 2025
Study Completion
October 17, 2025
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share